A Nonseminomatous Germ Cell Tumor Presenting as a Mixed Cryoglobulinemic Vasculitis.

IF 0.6 Q4 ONCOLOGY
Gabriel Cojuc-Konigsberg, Isabel Comte Natera, Blanca E López Graciano, Luis Gerardo Mosqueda López, José Alonso Rojo Ávila, Braulio Martínez, Juan C Ramírez-Sandoval
{"title":"A Nonseminomatous Germ Cell Tumor Presenting as a Mixed Cryoglobulinemic Vasculitis.","authors":"Gabriel Cojuc-Konigsberg,&nbsp;Isabel Comte Natera,&nbsp;Blanca E López Graciano,&nbsp;Luis Gerardo Mosqueda López,&nbsp;José Alonso Rojo Ávila,&nbsp;Braulio Martínez,&nbsp;Juan C Ramírez-Sandoval","doi":"10.1155/2022/3326761","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mixed cryoglobulinemia syndrome (MCS) is a rare entity with a variety of causes but has not been associated with testicular germ cell tumors. We present here a case of a patient with a nonseminomatous germ cell tumor (NSGCT) presenting as a type III mixed cryoglobulinemic vasculitis. <i>Case Presentation</i>. A 58-year-old male exhibited typical clinical features of vasculitis, including weakness, fatigue, palpable purpura, multiple mononeuropathy, and a low C4 level. An MCS diagnosis was confirmed by the presence of cryoglobulins (6%) with polyclonal IgM and IgG components and biopsy proven leukocytoclastic vasculitis. Concomitantly, a stage IIIC (TxNxM1bS1) germ tumor with marked elevation of serum beta-human chorionic gonadotropin (2764 mUI/mL) was diagnosed. An aggressive treatment was needed, including methylprednisolone pulses, plasmapheresis, rituximab, followed by orchiectomy, and chemotherapy (bleomycin/etoposide/cisplatin). After tumor resection and treatment, cryoglobulins decrease to 0%, suggesting a paraneoplastic origin of the vasculitis.</p><p><strong>Conclusion: </strong>To the best of our knowledge, this is the first case of MCS possibly attributable to a NSGCT. This case further elaborates on the presentation of mixed cryoglobulinemia vasculitis and adds to the published literature on the topic.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803560/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Oncological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/3326761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Mixed cryoglobulinemia syndrome (MCS) is a rare entity with a variety of causes but has not been associated with testicular germ cell tumors. We present here a case of a patient with a nonseminomatous germ cell tumor (NSGCT) presenting as a type III mixed cryoglobulinemic vasculitis. Case Presentation. A 58-year-old male exhibited typical clinical features of vasculitis, including weakness, fatigue, palpable purpura, multiple mononeuropathy, and a low C4 level. An MCS diagnosis was confirmed by the presence of cryoglobulins (6%) with polyclonal IgM and IgG components and biopsy proven leukocytoclastic vasculitis. Concomitantly, a stage IIIC (TxNxM1bS1) germ tumor with marked elevation of serum beta-human chorionic gonadotropin (2764 mUI/mL) was diagnosed. An aggressive treatment was needed, including methylprednisolone pulses, plasmapheresis, rituximab, followed by orchiectomy, and chemotherapy (bleomycin/etoposide/cisplatin). After tumor resection and treatment, cryoglobulins decrease to 0%, suggesting a paraneoplastic origin of the vasculitis.

Conclusion: To the best of our knowledge, this is the first case of MCS possibly attributable to a NSGCT. This case further elaborates on the presentation of mixed cryoglobulinemia vasculitis and adds to the published literature on the topic.

Abstract Image

Abstract Image

Abstract Image

表现为混合性冷球蛋白血症性血管炎的非半细胞性生殖细胞肿瘤。
背景:混合性冷球蛋白血症综合征(MCS)是一种罕见的疾病,病因多种多样,但尚未与睾丸生殖细胞肿瘤相关。我们在此报告一例非半细胞瘤性生殖细胞肿瘤(NSGCT),表现为III型混合性冷球蛋白性血管炎。案例演示。一名58岁男性,表现出典型的血管炎临床特征,包括虚弱、疲劳、可触及的紫癜、多发性单神经病变和低C4水平。MCS的诊断是通过存在含有多克隆IgM和IgG成分的冷球蛋白(6%)和活检证实的白细胞破碎性血管炎。同时,诊断为IIIC期(TxNxM1bS1)生殖肿瘤,血清β -人绒毛膜促性腺激素显著升高(2764 mUI/mL)。需要积极的治疗,包括甲基强的松龙脉冲、血浆置换、利妥昔单抗、睾丸切除术和化疗(博来霉素/依托泊苷/顺铂)。肿瘤切除和治疗后,冷球蛋白下降至0%,提示血管炎的副肿瘤起源。结论:据我们所知,这是首例可能由NSGCT引起的MCS病例。本病例进一步阐述了混合性冷球蛋白血症血管炎的表现,并增加了有关该主题的已发表文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
11
审稿时长
16 weeks
期刊介绍: Case Reports in Oncological Medicine is a peer-reviewed, Open Access journal that publishes case reports and case series related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信